149 related articles for article (PubMed ID: 20640484)
21. Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen.
Gram J; Munkvad S; Jespersen J
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):438-42. PubMed ID: 2372037
[TBL] [Abstract][Full Text] [Related]
22. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
23. Quantifying changes in fibrin fiber network morphology.
Pretorius E
Ultrastruct Pathol; 2011 Aug; 35(4):150-4. PubMed ID: 21568621
[TBL] [Abstract][Full Text] [Related]
24. Excessive deposition of fibrin, platelets and platelet thrombi on vascular subendothelium during contraceptive drug treatment.
Inauen W; Baumgartner HR; Haeberli A; Straub PW
Thromb Haemost; 1987 Jun; 57(3):306-9. PubMed ID: 3660332
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
Palovaara S; Pelkonen O; Uusitalo J; Lundgren S; Laine K
Clin Pharmacol Ther; 2003 Oct; 74(4):326-33. PubMed ID: 14534519
[TBL] [Abstract][Full Text] [Related]
26. Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis.
Pretorius E; Oberholzer HM; van der Spuy WJ; Swanepoel AC; Soma P
Rheumatol Int; 2012 Jun; 32(6):1611-5. PubMed ID: 21331577
[TBL] [Abstract][Full Text] [Related]
27. Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk.
Johansson T; Fowler P; Ek WE; Skalkidou A; Karlsson T; Johansson Å
Stroke; 2022 Oct; 53(10):3107-3115. PubMed ID: 35735009
[TBL] [Abstract][Full Text] [Related]
28. Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients.
Pretorius E; Steyn H; Engelbrecht M; Swanepoel AC; Oberholzer HM
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):696-700. PubMed ID: 22001525
[TBL] [Abstract][Full Text] [Related]
29. Stroke in women - oral contraception, pregnancy, and hormone replacement therapy.
Rantanen K; Tatlisumak T
Curr Vasc Pharmacol; 2013 Jan; 11(1):58-73. PubMed ID: 22724472
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
[TBL] [Abstract][Full Text] [Related]
31. Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.
Melis GB; Fruzzetti F; Paoletti AM; Carmassi F; Fioretti P
Contraception; 1984 Dec; 30(6):575-83. PubMed ID: 6241562
[TBL] [Abstract][Full Text] [Related]
32. Novel use of scanning electron microscopy for detection of iron-induced morphological changes in human blood.
Pretorius E; Vermeulen N; Bester J; Lipinski B
Microsc Res Tech; 2013 Mar; 76(3):268-71. PubMed ID: 23280783
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
34. Investigating the ultrastructure of platelets of HIV patients treated with the immuno-regulator, Canova: a qualitative scanning electron microscopy study.
Pretorius E; Smit E; Oberholzer HM; Steyn E; Briedenhann S; Franz RC
Histol Histopathol; 2009 Apr; 24(4):399-405. PubMed ID: 19224442
[TBL] [Abstract][Full Text] [Related]
35. Comparisons of the fibrin networks during pregnancy, nonpregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope.
Pretorius E; Bronkhorst P; Briedenhann S; Smit E; Franz RC
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):12-6. PubMed ID: 20527721
[TBL] [Abstract][Full Text] [Related]
36. Comparative ultrastructural analyses of mouse, rabbit, and human platelets and fibrin networks.
Pretorius E; Humphries P; Ekpo OE; Smit E; van der Merwe CF
Microsc Res Tech; 2007 Sep; 70(9):823-7. PubMed ID: 17576129
[TBL] [Abstract][Full Text] [Related]
37. [Endocrinology].
Meyer P; Meier CA
Rev Med Suisse; 2006 Jan; 2(47):15-8. PubMed ID: 16465939
[TBL] [Abstract][Full Text] [Related]
38. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
den Tonkelaar I; Oddens BJ
Contraception; 1999 Jun; 59(6):357-62. PubMed ID: 10518229
[TBL] [Abstract][Full Text] [Related]
39. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
40. Part 2: ultrastructural changes of fibrin networks during three phases of pregnancy: a qualitative investigation.
Swanepoel AC; Lindeque BG; Swart PJ; Abdool Z; Pretorius E
Microsc Res Tech; 2014 Aug; 77(8):602-8. PubMed ID: 24861478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
